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Abstract
Background: Here we present convergent methodologies using theoretical calculations, empirical assessment on in-house
and publicly available datasets as well as in silico simulations, that validate a panel of SNPs for a variety of necessary tasks in
human genetics disease research before resources are committed to larger-scale genotyping studies on those samples.
While large-scale well-funded human genetic studies routinely have up to a million SNP genotypes, samples in a human
genetics laboratory that are not yet part of such studies may be productively utilized in pilot projects or as part of targeted
follow-up work though such smaller scale applications require at least some genome-wide genotype data for quality control
purposes such as DNA ‘‘barcoding’’ to detect swaps or contamination issues, determining familial relationships between
samples and correcting biases due to population effects such as population stratification in pilot studies.
Principal Findings: Empirical performance in classification of relative types for any two given DNA samples (e.g., full
siblings, parental, etc) indicated that for outbred populations the panel performs sufficiently to classify relationship in
extended families and therefore also for smaller structures such as trios and for twin zygosity testing. Additionally, familial
relationships do not significantly diminish the (mean match) probability of sharing SNP genotypes in pedigrees, further
indicating the uniqueness of the ‘‘barcode.’’ Simulation using these SNPs for an African American case-control disease
association study demonstrated that population stratification, even in complex admixed samples, can be adequately
corrected under a range of disease models using the SNP panel.
Conclusion: The panel has been validated for use in a variety of human disease genetics research tasks including sample
barcoding, relationship verification, population substructure detection and statistical correction. Given the ease of
genotyping our specific assay contained herein, this panel represents a useful and economical panel for human geneticists.
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Introduction
While microarray SNP genotype data are the standard genotype
data in human genetics there will still be a financially motivated
need for lower throughput genotyping to accomplish a range of
tasks prior to larger investments. Thus when dense whole genome
SNP or whole genome sequence data are not available, as is the
case in pilot studies and other instances when further genotyping
would be cost prohibitive (e.g. targeted measured genotype
approaches on very large population samples or follow-up
genotyping on a replication cohort after a large discovery phase),
it is more economic to use a small number of SNPs for: 1) Unique
barcoding of DNA samples for quality assurance to detect sample
swaps and contamination; an important step even in small pilot
studies. 2) Verification of family relationships even in small
structures such as parent-child trios is important given a general
non-paternity rate estimated to be ,3% [1]. 3) Adjustment of
case-control association sample sets to control for potential type I
error when case and control samples may systematically differ in
their genetic backgrounds based on population substructure [2]. In
this case, it is possible to perform either analysis that uses
quantitative admixture information as a covariate to return the
statistical test of size to nominal levels, or analyze subsets of the
data based on genetic background and use a meta-analysis or
other method to combine information across the populations.
Either correction method requires genome wide information for
the quantification or detection, respectively, of population
substructure.
Butler et al. [3] summarized a discussion of the 2007 meeting of
International Society of Forensic Genetics including a classifica-
tion of SNP markers based on the type of information provided by
the SNP. Forensic investigations often seek to uniquely identify a
DNA sample and to assign a DNA sample to an ancestral group.
The two goals require different classes of SNPs. ‘‘Individual
identification SNPs’’ have high heterozygosity while ‘‘ancestry
informative SNPs’’ have high differentiation between populations
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logical extremes, are necessarily mutually exclusive since the
highest FST values come from variants that are fixed in different
populations for opposite alleles (i.e., little or no heterozygosity in
any single population). Thus, if a small number of SNPs is being
chosen for a given purpose, those SNPs may not have desirable
properties for both individual identification and ancestry. For
example, Kidd et al [4] selected a panel of 19 SNPs that were
specifically chosen to minimize FST to create a universal SNP
panel for individual identification that was not dependant upon
ancestry. The 19 SNP panel achieves its stated goal and is
therefore not informative for ancestry. On the other end of the
spectrum, a 93 SNP panel was selected for large FST values by
Nassir [5] that is useful for ancestry assignment, but may not be as
useful for personal identification except that some of the 93 SNPs
provide some information on individual identity since a proportion
show some heterozygosity in certain populations.
Recently, a panel of 52 SNPs was selected for use in forensic
investigations [6] with the stated goal of individual identification
across populations [6,7,8,9,10,11,12]. This particular panel is
promising as the number of SNPs is easily multiplexed in one or at
most two assays for processing which makes this scale of marker set
ideal in terms of both cost and information content. Tracking
samples in a human disease genetics lab by obtaining unique
profiles of polymorphic markers (sp called ‘barcoding’) is akin to
comparing sample identity to a reference sample, except for
human disease genetics applications the reference sample is the
genotypes obtained when the sample was first processed in the lab
and deviations from that reference profile highlight quality
assurance issues. In addition, the selection of the 52 SNP panel,
while centering on SNPs with high overall heterozygosity for most
populations, also incuded a smaller proportion of SNPs showing
highly contrasting allele frequency distributions in particular
populations; raising the possibility that this SNP panel would also
be useful to detect and correct for population admixture. Lastly
any panel that is informative for individual identification in
different human populations is also applicable to relationship
testing provided that the majority of the composite SNPs are
unlinked - as is the case of the 52 SNP panel.
We sought to test these properties empirically, by examining the
52 SNP panel applied to a variety of common human genetics
tasks and analysis methods to verify the utility of this panel in these
instances. We used a combination of publicly available data as well
as genotypes generated in-house through a set of two multiplexed
assays for these SNPs to assess the suitability of the panel for
barcoding, relationship checking and admixture detection. Addi-
tionally, since it is unclear if enough Ancestry Informative Markers
(AIMs) were included in the 52 panel to statistically control false
positive rates for case-control association analysis either quantita-
tively or through stratifying the sample based on identified
subgroups, we conducted a simulation study to determine the
approximate range of population stratification between European
and African populations where this panel would be most useful.
We compared the performance of the 52 SNP panel with two
other SNP panels from the literature comprising 19 and 93 SNPs
[4,5]. The 19 SNP panel represents the minimum amount of
information for optimal individual identification. In contrast, the
93 SNP panel consisted of AIMs selected to identify the
continental ancestries of subject groups for genetic studies and
demonstrated to be efficient for that purpose. We hypothesized
that the 52 SNP panel would perform in a comparable way to the
19 SNP panel for identification but would be unlikely to match the
performance of the 93 SNP AIM panel for assignment of ancestry
since this was not the primary purpose of the 52 SNP panel in the
first place. We also gauged the performance of the 52 SNP panel
for routine relationship verification (relationship checking) in
outbred extended pedigrees.
Results
The mean match probabilities obtained with the 52 SNP panel
for the CEPH pedigrees (1.97610
219) and HapMap samples
(CEU 4.14610
220; YRI 2.59610
215; CHB 4.25610
217; JPT
1.27610
216) were in line with previous estimates [4,6]. Even
though the CEPH pedigree sample contains related individuals,
the mean match probability is still lower than any non-European
population by 2 orders of magnitude. This reflected a slight
ascertainment bias in the SNP selection process where about 15%
of loci originally had population data for Europeans alone and in
several cases these showed later to have much less variability in
African and/or East Asian populations. When examining the
Human Genome Diversity Panel (HGDP) data from seven
populations the mean match probabilities were between 10
213
and 10
218. With Europe and Southwest Asia being the lowest and
sub-Saharan Africa the highest, a trend mirrored in the HapMap
samples. We note that certain markers in the 52 SNP panel are
sited on the same chromosome arm and have recombination rates
below 0.4, but no markers showed evidence of linkage disequilib-
rium in any sample. Dropping the least informative markers of any
same-arm set reduces the panel to 42 SNPs and increased the
mean match probability by no more than 3.3 orders of magnitude
and no less than 1.7 for each population. Therefore any one
profile for a given population (whether based on a subset reduced
to allow for linkage or the full set) will have a match probability
lower than the world population of ,7610
9, representing a
globally unique profile amongst unrelated individuals.
Table 1 presents the summary statistics for the distribution in
the number of matches for all possible pairs in each sample. The
distribution of matches was normally distributed in each sample as
indicated by central moments of the distributions including
skewness and kurtosis. The number of comparisons that comprised
the distributions are also listed as a general indicator of the relative
information contained in each distribution. The greatest number
of matches occurred in the CEPH pedigree sample, which is the
only sample to contain related individuals, though the average
number of matches is similar across all groups.
The CEPH pedigrees showed no evidence of misspecified
relationships or sample swaps based on RELCHECK analysis. We
calculated the difference between the most likely (and in this case,
correct) relationship and the next most likely relationship as a
measure of relationship resolving power. The average difference
was a likelihood ratio of 4.2 (SD=14.0, range 1.1 to 302.0). Upon
visual inspection most of the lower likelihood ratios were the
parent-child to half-sibling contrasts. Thus while low likelihood
ratios are not encouraging for the SNP panel to resolve
relationships, this particular contrast would cause Mendelian
inconsistencies if inappropriate adjustments were made to the
pedigree file, thus ensuring such a mistake would not be made.
Other relationship contrasts were much more readily resolved with
average likelihood differences of 2.5610
14 and 1.2610
54 for the
third and fourth most likely relationships versus the most likely
relationship.
Figure 1 shows the sensitivity of each marker set for detecting
population admixture. The figure supports previous data showing
that the 52 and 93 SNP panels can be used to efficiently identify
continental groups of Europe (CEU), Asia (CHB and JPT) and
Africa (YRI), though neither can differentiate CHB and JPT
population samples [5,12]. There was minimal overlap between
52 SNP Admixture Panel
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between CEU and YRI populations. As expected, the 19 SNP
panel fails to distinguish any populations based on these data.
We also simulated population stratification in a case-control
study design by using a mixture of CEU and YRI haplotype
frequencies, a difference in population disease rates, and by
varying the proportion of CEU haplotypes in each replicate.
Figures 2 and 3 shows the results when using no adjustment for
population stratification compared to analysis with adjustment by
listing type I error and estimated OR (real OR is always 1 under
null simulations). Under the 1.25 CEU-YRI disease prevalence
difference condition, both the 52 and 93 SNP panels performed
well in terms of type I error and estimated OR. When looking at
the more extreme 1.5 CEU-YRI disease prevalence difference
condition both panels continue to perform well, though the 93
SNP panel showed a slight advantage in absolute terms, but the
difference in estimated OR (or type I error rate) is still trivial thus
demonstrating the sufficiency of information from the 52 SNP
panel to statistically correct for population stratification over a
wide range of parameters.
Discussion
We examined a panel of 52 SNPs, originally selected for utility
in forensic investigations, to determine if this panel would also be
useful for human genetics researchers in a variety of common
applications in that field. Consistent with the original work on this
panel [6], we found mean match probabilities comparable to those
previously observed in four populations from the three continental
groups most commonly used as subjects in genetic analyses. In six
large pedigrees we found very similar distributions of identical
genotypes between pairs and no sample pair showed identical
profiles. Since pedigrees contain related individuals this confirms
the panel is sufficiently heterozygous to differentiate close relatives
though more evaluations would be needed for those pedigrees with
loops and significant levels of inbreeding. Consistent with the low
mean match probability and our observations in pedigrees, the
panel is clearly able to deliver a globally unique profile or barcode
for tracking samples and enable straightforward quality assurance
in human genetics research.
Our study also goes beyond the original characterization of the
52 SNP by Sanchez et al. [6] in several key ways. Firstly, we
assessed the ability of the panel to resolve complex relationships by
examining CEPH pedigrees with large sibships and three
generations. This covers the most common pedigree relationships
encountered in the human genetic literature. Exact likelihood
calculations provided a mechanism to quantify the resolving power
of the panel, which is far superior to the 19 SNP panel and only
marginally less efficient than choosing 500 SNPs with high minor
allele frequency uniformly distributed across the genome, a
procedure used in the many extended pedigrees projects in our
lab (data not shown).
Secondly, while Sanchez et al. [6] used classical hierarchical
clustering methods common in phylogenic analysis (Unweighted
Table 1. Descriptive statistics on the number of identical genotypes between all possible pairing of samples by group.
CEPH Pedigrees CEU HapMap YRI HapMap CHB HapMap JPT HapMap HGDP
Mean 21.9 19.5 24.7 22.2 22.7 17.1
SD 5.3 3.6 3.4 3.4 3.4 3.6
Skewness 0.19 0.14 0.14 0.12 0.15 0.07
Kurtosis 0.59 0.04 0.15 20.03 20.25 0.07
Minimum 4 8 13 12 13 2
Maximum 43 34 41 33 32 35
Number of comparisons 3828 3240 3240 903 861 452676
doi:10.1371/journal.pone.0019699.t001
Figure 1. Detection of population structure in four HapMap populations. The first two principal components from EIGENSTRAT are plotted
for all 3 SNP panels (A, SNP panel 93; B, SNP panel 52; C, SNP panel 19). As more AIMs are used in the analysis, the resolution improves. The 52 SNP
panel appears to have some overlap between CEU and CHB+JPT though it should be noted that these datapoints are more clearly differentiated by
considering the third and fourth principal components (not shown).
doi:10.1371/journal.pone.0019699.g001
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the panel to differentiate ancestries, in the human disease
discovery field this methodology is uncommon. Here we have
applied PCA to identify population structure using EIGEN-
STRAT, a common statistical package used in human disease
discovery projects. Our results are qualitatively similar to the
hierarchical clustering of Sanchez et al. [6] which, based on
different DNA samples, also showed the 52-SNP panel was able to
distinguish 3 major populations, that of European, African and
Asian. Thirdly, and perhaps most importantly, we examined if the
panel provided enough information about population structure to
quantitatively correct the effect of admixture in case-control
association analysis. The data support the conclusion that
population stratification between CEU and YRI populations can
effectively be corrected with this panel though when such
corrections are inadequate, it is at least possible to detect that
admixture is present.
This study is limited by the data structures examined and our
modeling assumptions for the simulations. In the former case, we
have assessed the information content of this panel to identify
more distant relationships than avuncular. It would be expected
that half-sib relationships and cousins would be reasonable to
detect with this panel but more distant relationships would clearly
be more difficult to resolve while inbreeding and marriage loops
may not be sufficiently differentiated from sibling or parent-child
relationships to be reliably detected. Additionally, since the data
presented here is based on slightly fewer SNPs than the full panel
(48 for HapMap data or 49 for our CEPH family genotyping) the
resolving power of the panel is marginally underestimated. It is
worth noting that the inclusion of dedicated ancestry informative
Figure 2. Analysis of case-control study type I error rates from 3 simulated SNPs within BDNF. The three SNPs show allele frequency
differences between CEU and YRI of 0.066 (rs11030108), 0.102 (rs10767658), and 0.233 (rs1013402). The y-axis is estimated type I error rate versus the
simulated CEU proportion (x-axis). Panels on the left show data with a difference in disease prevalence ratio of 1.25 while a ratio of 1.5 is shown on
the right.
doi:10.1371/journal.pone.0019699.g002
52 SNP Admixture Panel
PLoS ONE | www.plosone.org 4 May 2011 | Volume 6 | Issue 5 | e19699marker SNPs such as rs1426654 (fixed in Europeans) or rs2814778
(fixed in Africans) to augment the above identification loci would
further strengthen the ability of this multiplex to differentiate the
major population groups [12].
For evaluating false positives in case-control analysis, we only
simulated a limited number of disease models and while the
simulations are realistic for the relationship between the SNPs for
each population (due to use of real genotype sets), it is clear that
simple combinations of populations differing in cases and controls
is not a fully realistic simulation of stratification in real populations.
However, it is clear that our model does capture the end result of
continuous and gradual admixture, which is most important for
understanding if the SNP panel presents a viable strategy for
statistical correction.
We have evaluated a panel of 48 SNPs (derived from a
published set of 52) and presented a method for two multiplex
PCR/LDR assays for those SNPs. This panel of SNPs is suitable
for sample quality assurance in many human genetics research lab
in the form of sample barcoding to detect sample swaps and
contamination as demonstrated by the extremely low probability
of two samples having identical profiles. Relationship checking in
simple extended pedigree structures is clearly possible given the
resolving power of the SNP panel, although the effect of the
reduced variability when inbreeding or marriage loops may be
present in the pedigree or when analyzing more distant
relationships beyond cousin pairs, remains to be explored.
Consistent with previous work on population inference with this
panel, three broad population groups may be readily distinguished
(European, African, East Asian) and within those broad categories
several subgroups are also distinguishable. However, the purpose
of the panel as presented here for human disease genetics is not to
assess samples for categorizing into population groups, rather the
purpose is to capture variance attributable to different populations
that is necessary to correct for population stratification in case
Figure 3. Estimated odds ratios (OR) from case-control analysis of 3 simulated SNPs within BDNF. Conventions are the same as Figure 2
except the y-axis is the average estimated OR from the same analysis as presented in Figure 2.
doi:10.1371/journal.pone.0019699.g003
52 SNP Admixture Panel
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information over a range of disease models and population
stratification scenarios.
Methods
Samples
For testing population identification we used publicly available
samples and genotyping data selected from HapMap [13] (Phase
3) for European sample: CEU (Utah residents with ancestry from
northern and western Europe), African: YRI (Yoruba in Ibadan,
Nigeria), Japanese: JPT (Japanese in Tokyo, Japan) and Chinese:
CHB (Han Chinese in Beijing, China). Genotype data for the
composite markers of the three different SNP panels was
downloaded from the HapMap website (http://hapmap.ncbi.
nlm.nih.gov/). The first SNP panel, developed by Kidd and
colleagues [4], comprises 19 SNPs, with 17 characterised in all
four populations of HapMap (rs1358856 and rs7520386 lack data).
From the 1000 Genome Project data, we found a proxy SNP
rs1358855 for rs1358856 (pairwise r
2 between these two SNPs was
0.97, 1.0 and 1.0 for CEU, CHB+JPT and YRI respectively). The
second SNP panel of 52 SNPs, previously developed for forensic
analysis by the SNPforID Consortium [6], of which 48 can be
found in all of 4 populations (rs826472, rs2016276, rs938283 and
rs722098 lack data). All 93 SNPs of the third AIM-SNP panel [5],
are characterized in all 4 HapMap populations, though only a
subset of these SNPs was genotyped for HapMap phase 3
individuals, so only phase 2 population data was used for ancestry
analyses we performed. After quality control (removal of
individuals with greater than 5% missing genotypes), the sample
sizes for CEU, YRI, CHB and JPT reduced to 81, 81, 43 and 42
respectively. For mean match probability, we also used data from
the Human Genome Diversity Panel [14], divided into seven
continental groups Oceana, South Asia, East Asia, Sub-Saharan
Africa, North and South America, and Europe. A total of eight
SNPs (rs1029047, rs2107612, rs873196, rs1382387, rs2111980,
rs938283, rs1028528, rs1528460) cannot be found in all
continental groups from HGDP files and were not used for
calculation.
For gauging the ability of SNP sets to resolve relationships we
genotyped a series of families from the Centre d"Etude du
Polymorphisme Humain (CEPH) collection [15] available through
The Coriell Cell Repositories http://ccr.coriell.org. Each family
consists of a large sibship plus both parents and both sets of
grandparents available for genotyping. Family numbers were
1451, 1454, 1456, 1458, 1459 and 1463 with a total of 88 samples
for genotyping.
Genotyping
Single nucleotide polymorphism genotyping: Genotyping was
performed by multiplex PCR of amplicons containing the 52 SNPs
followed by the ligase detection reaction (LDR) method of Bruse et al.
[16] on a Luminex 200 Multiplex Bio-Assay Analyzer. Assay details
are presented in Table 1. All samples were stored and handled as
described previously [17]. Genotypes were called based on the same
metric as Bruse et al [16] but initial clustering analysis was conducted
by in-house Ruby 1.8.6 scripts applying the AI4R library (http://ai4r.
rubyforge.org/) clustering routines and the Tioga graphics library
(http://www.itp.ucsb.edu/,paxton/tioga.html). This script automat-
ically produces allele intensity plots color coded by called genotype. All
plots were visually inspected (by CWB); SNPs that did not cluster
appropriately were dropped (N=3; rs733164, rs907100, rs938283), as
this is indicative of an assay failure, leaving a total of 49 of 52 SNPs
with robust genotype information.
Genotype cleaning: All genotype data was automatically
processed once generated via in-house Ruby 1.8.6 scripts for
consistency and to minimize human errors. Files containing the
called genotypes were output to a pre-MAKEPED linkage format
file [18]. A linkage format locus data file was generated to form the
two required inputs to PEDCHECK v1.1 [19] which detects all
Mendelian inconsistencies. PEDCHECK output was tabulated
and merged with raw allele intensity data for manual evaluation of
the genotype calls in the flagged nuclear family containing the
error. Ambiguous genotypes were repeated (N=9 out of a total of
4312 genotypes). No genotypes were excluded after repeating.
PEDSTATS v0.6.3 was used to check markers for Hardy-
Weinberg equilibrium using the founders only functions [20].
No markers were flagged as deviating from Hardy-Weinberg
equilibrium at the P,0.05 level. No SNPs showed significant
linkage disequilibrium (D’) in either the HapMap data or in
our CEPH pedigrees as determined by maximum likelihood
estimation.
Simulations
HAP-SAMPLE [21], a data based resampling simulation tool,
was used to simulate genetically realistic genotypes for SNPs in the
three panels plus SNPs in a candidate gene under a null model (in
this case, brain-derived neurotrophic factor or BDNF). HAP-
SAMPLE is based on a pool of phased chromosomes estimated
from genotyped HapMap samples. Using a resampling approach
that assumes random mating and implements crossovers as part of
simulated meiosis, HAP-SAMPLE can be used to create artificial
case-control samples of arbitrary size that possess realistic patterns
of linkage disequilibrium and genotype distributions. In our study,
simulations proceeded as follows: firstly, 10,000 CEU cases and
10,000 CEU controls were generated based on HapMap CEU
data, and 10,000 YRI cases and 10,000 YRI controls were
generated based on YRI data, secondly, 500 cases and 500
controls were randomly selected from CEU & YRI cases and CEU
& YRI controls, respectively. The specific number of samples
selected from each group (CEU cases, CEU controls, YRI cases,
YRI controls) was determined by two factors, 1) CEU proportion
and 2) degree of population stratification defined as the ratio of
disease prevalence between CEU and YRI populations being
greater than 1. For example, if the CEU proportion in the final
sample is 50% and under moderate population stratification (the
prevalence of the disease was 1.25 fold higher in CEU than YRI),
then the CEU cases should be 278, CEU controls should be 222,
YRI cases should be 222, YRI controls should be 278. Each
combination of the following parameter sets was simulated 1000
times. CEU proportion was varied in the set [0.05, 0.1, 0.15, 0.2,
0.25, 0.3, 0.4, 0.5]. Ratio of disease prevalence CEU:YRI was
either 1.25 or 1.5.
Statistics
Mean match probability was calculated as the sum of the
squared genotype frequencies per locus. This procedure was
applied twice, once using all of the markers and once excluding the
less informative of any two SNPs that were estimated to have a
recombination fraction ,0.4 (i.e, linked) for total of N markers
dropped. Using estimated genotype frequencies for HapMap
samples mean match probability was calculated by population and
identically estimated for the in-house genotyped CEPH pedigrees.
Relationship testing performance was checked using RE-
LCHECK, which estimates identity by state (IBS) relationship
values between each pair of individuals. A log10 likelihood (LOD)
score is calculated over 5 contrasting relationships (parent-child,
full sibling, half sibling, monozygotic twin and unrelated). The
52 SNP Admixture Panel
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pair is the most likely pairwise relationship. LOD differences
between the most likely relationship and the correct relationship
were calculated. If this value was zero, the difference between the
correct relationship and second most likely relationship was used a
measure of resolving power.
Populations were resolved by principal component analysis of
the SNP genotype data as implemented in EIGENSTRAT [22].
EIGENSTRAT was used to calculate the principal component
analysis (PCA) scores for each SNP panel, and the first 4 principal
components were put into a logistic regression model to adjust for
population stratification in the simulated data. We compare
analysis of the data with and without the population stratification
adjustment by plotting changes in type I error and estimated odds
ratio (OR).
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